guidelines that instruct on the use of DMARDs and, taken together, can guide a shared decision-making approach between the individual with RA and their clinician. Interprofessional treatment teams are crucial to implementing these recommendations. The generally low-quality evidence highlights the need for well-designed studies in the area of integrative management of RA. Policy efforts are needed to ensure access to recommended interventions for individuals with RA from diverse backgrounds and